对粘膜层莱什曼病的治疗方法的成本效益研究
Janaína de Pina Carvalho1, Gláucia Cota1, Mariana Lourenço Freire1
1Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brasil.
Cadernos de saude publica
|August 21, 2024
概括
这项研究评估了巴西粘膜层莱什曼病治疗的成本效益. 梅格胺抗酸和氧菲林的组合非常具有成本效益,而米尔特福辛则非常具有成本效益.
科学领域:
- * 卫生经济学
- * 热带医学 热带医学
- * 药理学 药理学 药理学
背景情况:
- * 粘膜莱什曼病在巴西造成了严重的健康负担.
- * 存在多种治疗方案,但它们在巴西统一国家卫生系统 (SUS) 内的成本效益需要评估.
- *了解治疗成本和患者的治疗结果对于资源分配至关重要.
研究的目的:
- * 估计和比较巴西的四种粘膜层莱什曼病治疗方法的成本效益:米尔特福辛,梅格胺抗酸,梅格胺抗酸与托西菲林,和脂肪体安福特乙酸.
- * 采用巴西统一国家卫生系统 (SUS) 的观点.
- * 为了分析
- 主要_方法 方法
- * 采用决策树模型来分析结果
- 主要_结果
- * 结合梅格胺抗酸和氧菲林,证明每治愈患者的增量成本效益比 (ICER) 高达85.13美元,非常有利.
- * 脂质体安福特里辛B呈现出显著更高的ICER,即每位治愈患者的ICER为7409.13美元.
- * 由于成本较高和效率相似,Miltefosine被发现仅由meglumine反酸盐占主导地位,除非其价格低于171.23.3美元.
主要方法:
- * 采用决策树模型来分析结果
- 结论 结论 结论 结论
- * 结合梅格胺抗酸和氧菲林是巴西粘膜层莱什曼病的最具成本效益的策略.
- *Miltefosine的成本效益高度敏感于其采购价格,突出其作为口服治疗选择的潜在价值.
- * 建议对药物价格进行谈判,并促进技术转让,以改善巴西医疗保健系统内粘膜病治疗的获取和负担能力.
主要成果:
- * 结合梅格胺抗酸和氧菲林,证明每治愈患者的增量成本效益比 (ICER) 高达85.13美元,非常有利.
- * 脂质体安福特里辛B呈现出显著更高的ICER,即每位治愈患者的ICER为7409.13美元.
- * 由于成本较高和效率相似,Miltefosine被发现仅由meglumine反酸盐占主导地位,除非其价格低于171.23.3美元.
结论:
- * 结合梅格胺抗酸和氧菲林是巴西粘膜层莱什曼病的最具成本效益的策略.
- *Miltefosine的成本效益高度敏感于其采购价格,突出其作为口服治疗选择的潜在价值.
- * 建议对药物价格进行谈判,并促进技术转让,以改善巴西医疗保健系统内粘膜病治疗的获取和负担能力.
更多相关视频
12:22A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
Published on: December 30, 2012
22.4K
11:36Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
Published on: April 21, 2012
22.0K
相关概念视频
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
